Scienture Holdings, Inc. (SCNX)
(Delayed Data from NSDQ)
$1.11 USD
-0.46 (-29.30%)
Updated Oct 27, 2025 04:00 PM ET
After-Market: $1.06 -0.05 (-4.50%) 7:14 PM ET
NA Value NA Growth NA Momentum NA VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SCNX 1.11 -0.46(-29.30%)
Will SCNX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SCNX based on the 1-3 month trading system that more than doubles the S&P 500.

Other News for SCNX
12 Health Care Stocks Moving In Monday's Intraday Session
Is SCNX showing upside potential? Jack-in-the-box Bullish shows up after plummeting 39.62%
12 Health Care Stocks Moving In Friday's Intraday Session
Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings
Crossed Above 20 Day Moving Average appears for SCNX after 354.94% move